Loading clinical trials...
Loading clinical trials...
Evaluation of iHealth COVID-19/Flu A&B Rapid Test for SARS-CoV-2 and Flu A&B Detection in Symptomatic Individuals
Conditions
Interventions
Investigational Flu A/B And Covid-19 Diagnostic Test
Locations
15
United States
iHealth Site 006
Birmingham, Alabama, United States
iHealth Site 021
Trussville, Alabama, United States
iHealth Site 017
Dublin, California, United States
iHealth Site 007
Huntington Park, California, United States
iHealth Site 008
Los Angeles, California, United States
iHealth Site 013
Doral, Florida, United States
Start Date
November 12, 2024
Primary Completion Date
December 12, 2025
Completion Date
December 12, 2025
Last Updated
January 8, 2026
NCT06672692
NCT07128615
NCT04896853
NCT06622590
NCT07430410
NCT05202379
Lead Sponsor
iHealth Labs inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions